ARCO three-lens brief
Evidence-based stock research on ARCO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Debt-to-equity of 264% — balance-sheet-heavy.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 6.6 — trading at a value multiple.
- Analyst mean target $11.29 — 40% above current (9 analysts).
- Debt-to-equity of 264% — balance-sheet-heavy.
- Ex-dividend date 2026-09-21.
ARCO closed at $8.06 (-0.37%) as of 2026-09-11. Market cap: $1.70B. P/E (trailing) 6.6. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 6.6 — trading at a value multiple.; analyst mean target $11.29 — 40% above current (9 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; debt-to-equity of 264% — balance-sheet-heavy.. Last quarter: Revenue $1.22B, net income $36.14M, free cash flow $128.89M.
Why three lenses on ARCO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARCOacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARCO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARCO brief"></iframe>